Recombinant Human MDA5/IFIH1 Protein, N-His

Introduction

Recombinant Human MDA5/IFIH1 Protein, also known as Melanoma Differentiation-Associated protein 5 or Interferon-Induced Helicase C Domain-Containing Protein 1, is a protein that plays a crucial role in the innate immune response against viral infections. This protein is encoded by the IFIH1 gene and is a member of the DEAD-box family of RNA helicases. In this article, we will discuss the structure, activity, and applications of Recombinant Human MDA5/IFIH1 Protein.

Structure of Recombinant Human MDA5/IFIH1 Protein

Recombinant Human MDA5/IFIH1 Protein is a 946 amino acid protein with a molecular weight of approximately 105 kDa. It consists of two N-terminal caspase recruitment domains (CARDs), a central DExD/H box helicase domain, and a C-terminal regulatory domain. The CARD domains are responsible for protein-protein interactions and signal transduction, while the helicase domain is involved in RNA binding and ATP hydrolysis. The C-terminal regulatory domain helps in the activation and regulation of the protein’s activity.

Activity of Recombinant Human MDA5/IFIH1 Protein

Recombinant Human MDA5/IFIH1 Protein is a key component of the innate immune system and is involved in the detection of viral RNA. It recognizes double-stranded RNA (dsRNA) produced during viral replication and initiates a signaling cascade that leads to the production of type I interferons and pro-inflammatory cytokines. This activation of the innate immune response helps in the clearance of viral infections.

The helicase domain of Recombinant Human MDA5/IFIH1 Protein plays a crucial role in its activity. It is responsible for binding to dsRNA and catalyzing the ATP-dependent unwinding of the RNA, which is essential for the activation of downstream signaling pathways. The CARD domains are also important for the protein’s activity as they interact with other proteins, such as the mitochondrial antiviral signaling protein (MAVS), to activate downstream signaling.

Applications of Recombinant Human MDA5/IFIH1 Protein

Recombinant Human MDA5/IFIH1 Protein has several applications in both research and clinical settings. Its ability to detect viral infections and initiate an immune response makes it a valuable tool in the study of viral pathogenesis. It is also used in the development of antiviral therapies and vaccines.

In clinical settings, Recombinant Human MDA5/IFIH1 Protein can be used as a diagnostic tool for viral infections. Its elevated levels in the blood have been associated with viral diseases, such as hepatitis C and influenza. This makes it a potential biomarker for the diagnosis and monitoring of these diseases.

Moreover, Recombinant Human MDA5/IFIH1 Protein has also been studied as a potential therapeutic target for autoimmune diseases, such as type 1 diabetes and systemic lupus erythematosus. Its involvement in the innate immune response and regulation of inflammation makes it a promising target for the treatment of these diseases.

Conclusion

Recombinant Human MDA5/IFIH1 Protein is a vital component of the innate immune system with important roles in the detection and clearance of viral infections. Its structure, activity, and applications make it a valuable tool in the study of viral pathogenesis and the development of antiviral therapies. Furthermore, its potential as a diagnostic and therapeutic target for autoimmune diseases highlights its significance in both research and clinical settings.